First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE).Yuankai Shi, Fenlai Tan, Ping Yu et al.|Journal of Clinical Oncology|2016Cited by 14
Effect of sequential chemotherapy and gefitinib on survival outcome in advanced NSCLC with acquired gefitinib resistance.Huijuan Wang, Ma Yong, Mina Zhang et al.|Journal of Clinical Oncology|2013Cited by 0